
Across June and July 2026, we will be hosting a series of events designed to accelerate progress on the most pressing issues in earlier cancer diagnosis, at a moment of significant political change and opportunity.
In collaboration with the cancer community, these events aim to respond to policy and clinical practice opportunities as we work to drive evidence into practice.
The events will explore critical questions such as:
How can primary care successfully optimise and innovate symptomatic risk assessment over the next 10 years?
How do we deliver the potential benefits of genomic medicine?
What are the implications of the UK NSC’s new position on surrogate outcomes in cancer screening?
How can we better navigate the rapidly expanding AI landscape?
For the latest news and updates relating to our ED Event Series and future conferences, please sign up to our Early Diagnosis Newsletter.
On 2 July, we hosted a webinar exploring how we can better navigate the rapidly expanding AI landscape for cancer in a way that supports consistent, evidence-based decision making. The event was open to anyone but was of particular interest to cancer policymakers and clinical leads, cancer transformation and improvement organisations and those supporting the translation of cancer innovation into practice. Our expert speakers used real world examples to illustrate the challenges of evaluating, prioritising and adopting AI tools for cancer, and discussed how health systems could make consistent, evidence-based decisions on the adoption of AI tools.
The speakers were:
Professor Alastair Denniston (Executive Director at CERSI-AI, Chair of the National Commission into the Regulation of AI in Healthcare)
Dr Chris Johns (Consultant Thoracic Radiologist, Sheffield Teaching Hospitals)
Rob Dale (Head of AI, Diagnostics, NHSE)
Jason White (National Head of Innovations, CfSD)
A recording of the event will be made available shortly.
If you have any questions or want to know more about this events series, please contact EDConference@cancer.org.uk.
During the pandemic, we shifted to Virtual Events which were hugely successful. Read more about our previous virtual sessions. Read more about our previous sessions.
Cancer Research UK have been running Early Diagnosis conferences since 2011. Our next in-person conference will take place in 2027. Sign up to the Early Diagnosis newsletter for updates.
If you have any questions or suggestions for future topics, please contact the